Previous 10 | Next 10 |
home / stock / vphif / vphif news
VALEO PHARMA REPORTS ITS SECOND QUARTER 2022 RESULTS AND HIGHLIGHTS Canada NewsWire Q2-22 revenues of $4.8 million , up 80% over Q2-21 Q2-22 gross margins of $1.7 million , up 134% over Q2-21 Canadian provincial public reimbursement now co...
VALEO PHARMA TO HOST SECOND QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , June 8, 2022 /CNW Telbec/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical...
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, APPOINTMENTS AND OPTIONS AND RSU GRANTS Canada NewsWire MONTREAL , April 28 , 2022 /CNW/ - Valeo Pharma Inc . (TSX:VPH) (OTCQB: VPHIF) (FSE:VP2) (" Valeo " or the " Company "), ...
VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE Canada NewsWire MONTREAL , April 25, 2022 /CNW Telbec/ - Valeo Pharma I...
VALEO PHARMA ANNOUNCES LISTING OF CONVERTIBLE DEBENTURES ON TSX Canada NewsWire MONTREAL , April 19, 2022 /CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, is p...
VALEO PHARMA ANNOUNCES LISTING TO THE TORONTO STOCK EXCHANGE Canada NewsWire The Company's shares and warrants to start trading on March 29th, 2022 MONTREAL , March 28, 2022 /CNW Telbec/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHI...
Valeo Pharma press release (OTCQB:VPHIF): FQ1 net loss of C$5.9M. Revenue of C$4.2M (+121.1% Y/Y). For further details see: Valeo Pharma net loss of C$5.9M, revenue of C$4.2M
VALEO PHARMA REPORTS ITS FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS Canada NewsWire Q1-22 revenues of $4.2 million , up 128% over Q1-21 Q1-22 gross margins of $1.4 million , up 266% over Q1-21 Public reimbursement secured in key provinc...
VALEO PHARMA SECURES ADDITIONAL PUBLIC REIMBURSEMENT FOR REDESCA™, ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® Canada NewsWire Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia ...
VALEO PHARMA TO HOST FIRST QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST AND ATTEND THE 8TH ANNUAL ALPHANORTH CAPITAL CONFERENCE Canada NewsWire MONTREAL , March 17, 2022 /CNW Telbec/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " o...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...